Daniel Eun, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Histiosonics
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    12/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other (Oncology)
    Ineligible company: 
    Hitachi Aloka
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    12/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (Robotic Surgery)
    Ineligible company: 
    Intuitive Surgical
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    12/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Robotic Surgery)
    Ineligible company: 
    Johnson and Johnson
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    12/16/2022
Return to Update Series (2023) Lesson 28: Contemporary Diagnosis and Management of Ureteropelvic Junction Obstruction in Adults